2007
DOI: 10.1016/j.apradiso.2006.11.001
|View full text |Cite
|
Sign up to set email alerts
|

99mTc(CO)3-VIP analogues: Preparation and evaluation as tumor imaging agent

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
9
0
2

Year Published

2011
2011
2020
2020

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 18 publications
(11 citation statements)
references
References 11 publications
0
9
0
2
Order By: Relevance
“…As an example, the synthesis of a series of M(CO) 3 -based (M = Re, Tc) Carbonic Anhydrase IX inhibitors was developed using Re(CO) 3 , while the affinity for CA-IX was evaluated using the final 99m Tc complexes [77]. Peptides were also labelled with Re/Tc tricarbonyl complexes, generally in order to target specific cell lines or events [86][87][88][89]. In most of these examples, the rhenium is used for its reactivity close to the technetium and for the similarities of the Re and Tc complexes.…”
Section: Re(co) 3 As Surrogates For 99mmentioning
confidence: 99%
“…As an example, the synthesis of a series of M(CO) 3 -based (M = Re, Tc) Carbonic Anhydrase IX inhibitors was developed using Re(CO) 3 , while the affinity for CA-IX was evaluated using the final 99m Tc complexes [77]. Peptides were also labelled with Re/Tc tricarbonyl complexes, generally in order to target specific cell lines or events [86][87][88][89]. In most of these examples, the rhenium is used for its reactivity close to the technetium and for the similarities of the Re and Tc complexes.…”
Section: Re(co) 3 As Surrogates For 99mmentioning
confidence: 99%
“…Kothari et al (62) synthesized three VIP analogs functionalized at the N terminus with histidine [VP05 (28 residue), VD4 (20 residue), VD5 (19 residue)] by solid phase synthesis and radiolabeled the VIP analogs with 99m Tc via a novel tricarbonyl synthon. All of the radiolabeled complexes were stable at room temperature and were produced with high yields.…”
Section: M Tc-labeled Vip Analogs For Receptor Imagingmentioning
confidence: 99%
“…For therapy, the radiopharmaceuticals must contain radionuclides emitting ionizing particles (Auger electrons, β − or α particles) to target and damage tumor tissues. Several radiometals have nuclear decay properties suitable for therapeutic applications, such as the β − -emitting isotopes 186 Re and 188 Re (Table 1).…”
Section: Introductionmentioning
confidence: 99%